Sunitinib Price in India: — Brand, Generic and Monthly Cost

DCGI-approved generic sunitinib must pass bioequivalence testing before it can be sold in India. Bioequivalence means the generic delivers the same amount of active drug — sunitinib malate — into your bloodstream at the same rate as the originator. The active ingredient is chemically identical. Your oncologist can confirm whether a specific approved generic is appropriate for your treatment, but regulatory approval means the clinical evidence standard has been met.

DCGI-approved generic sunitinib is stocked at hospital pharmacies attached to oncology centres and at larger medical retailers in most cities. Hospital pharmacies are the best starting point — they often carry the generics their oncology team is familiar with, and prices are frequently lower than retail medical shops. Ask your oncology team which pharmacy they recommend and whether the hospital can supply it directly.

Switching between bioequivalent forms is generally considered acceptable, but this is a conversation to have with your oncologist before you make the change, not after. Your oncologist will want to know so they can monitor your response as they would at the start of treatment. Do not switch without telling your team — and never reduce your dose or extend the rest period to make a pack last longer without a specific instruction to do so.

Coverage varies by policy. Some group health insurance policies include oral anticancer drugs and others exclude them. The key detail is whether your policy covers chemotherapy taken by mouth — check your policy document under 'cancer benefit' or 'oral chemotherapy', then call your insurer before spending out of pocket. If the insurer requires prior authorisation, your oncologist can provide the documentation needed.

Tell your oncologist directly that cost is a barrier. This is a common and important conversation in Indian oncology, and there are usually options to explore — government scheme coverage, hospital charity care, manufacturer assistance programmes, or in some cases an alternative treatment that is similarly effective and more affordable for your specific situation. Your oncologist and the hospital's social worker are the right people to involve. Do not reduce your dose or stop treatment without telling your team first.

The ranges shown are indicative, based on publicly available pricing information as of early 2025. Pharmaceutical prices in India change with policy decisions, generic competition, and import costs. Always confirm the current price at your hospital pharmacy before making a financial decision. The purpose of the ranges here is to give you a realistic sense of the cost difference between branded and generic options — not to quote the exact price you will pay.